{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:06:37Z","timestamp":1777482397417,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Biotherapy and Radiopharmaceuticals"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Chronic inflammation has been linked to the development and prognosis of neuroendocrine tumors (NETs). The current study intended to evaluate the role of peripheral hematological inflammatory markers, viz. the platelet\u2013lymphocyte ratio (PLR), neutrophil\u2013lymphocyte ratio, and monocyte\u2013lymphocyte ratio, as predictors of treatment outcomes in patients with advanced NETs after Lutetium-177(\n                      <jats:sup>177<\/jats:sup>\n                      Lu)-DOTATATE therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Data of consecutive patients with advanced metastatic and\/or inoperable NETs treated with\n                      <jats:sup>177<\/jats:sup>\n                      Lu-DOTATATE from the year 2012 to 2019 at the authors' center were retrospectively analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Forty-two NET patients (median age: 49.5 years) received a median cumulative activity of 29.6 GBq of\n                      <jats:sup>177<\/jats:sup>\n                      Lu-DOTATATE over 2\u20135 cycles at 8\u201312-week intervals. The median progression-free survival (PFS) of the study cohort was 30 months (95% confidence interval, CI: 18.2\u201341.9 months). A baseline PLR \u2265173.1 was found to be a significant predictor of poor PFS with a univariate hazard ratio of 3.82 (95% CI: 1.21\u201312.03); however, the association was not significant on multivariate analysis. The median overall survival was not reached and none of the parameters were significantly associated with it.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      A higher baseline PLR was shown to be associated with a negative outcome on PFS after\n                      <jats:sup>177<\/jats:sup>\n                      Lu-DOTATATE therapy and is a promising marker for future larger studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cbr.2021.0053","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:09:20Z","timestamp":1624979360000},"page":"23-29","source":"Crossref","is-referenced-by-count":6,"title":["Hematological Markers as Predictors of Treatment Outcomes with Lutetium 177 (\n                    <sup>177<\/sup>\n                    Lu)-DOTATATE in Patients with Advanced Neuroendocrine Tumors"],"prefix":"10.1177","volume":"37","author":[{"given":"Swayamjeet","family":"Satapathy","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-0361","authenticated-orcid":false,"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, and Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apurva","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Khosla","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000443167"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1902-1"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.125336"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2743"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3533-z"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01991"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1148\/rg.352140164"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0488"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-018-0517-x"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1033-0"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.224386"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20100136"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000107555"},{"key":"e_1_3_4_18_2","first-page":"69","article-title":"The biological relevance of gastric neuroendocrine tumors","volume":"69","author":"Kl\u00f6ppel G","year":"1996","unstructured":"Kl\u00f6ppel G, , Clemens A. The biological relevance of gastric neuroendocrine tumors. Yale J Biol Med, 1996; 69:69.","journal-title":"Yale J Biol Med"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(11)80445-0"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.03.006"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.5578\/turkjsurg.4375"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.907182"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.18068"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003170"},{"key":"e_1_3_4_25_2","first-page":"6275","article-title":"Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients","volume":"18","author":"Huszno J","year":"2019","unstructured":"Huszno J, , Kolosza Z. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients. Oncol Lett, 2019; 18:6275.","journal-title":"Oncol Lett"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5326-9"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2019.01.12"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2019.08.003"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5716"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S152657"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2018.06.058"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040855"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.52"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.134.1.230"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.139.7.2406"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i41.6248"}],"container-title":["Cancer Biotherapy and Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cbr.2021.0053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cbr.2021.0053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cbr.2021.0053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:16:03Z","timestamp":1777385763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cbr.2021.0053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1089\/cbr.2021.0053"],"URL":"https:\/\/doi.org\/10.1089\/cbr.2021.0053","relation":{},"ISSN":["1084-9785","1557-8852"],"issn-type":[{"value":"1084-9785","type":"print"},{"value":"1557-8852","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}